In a study with the breast cancer cell line MCF-7, metformin displayed inhibiting effects on MMP9 expression at 5.0 and 10.0 mmol/L after 24 h, whereas MMP2 levels were not affected [77]. Here, MMP9 is linked to breast carcinoma.